Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Jeff Dykan Biography and Net Worth

Director of ReWalk Robotics

Jeff Dykan has served on the ReWalk board since 2006 and has been its Chairman since 2009. Mr. Dykan has been a director of the corporate general partner of the common general partner of Vitalife and its successor fund, SCP Vitalife, an Israeli venture capital fund, since 2002 and 2007, respectively. Prior to joining Vitalife, from 2001 to 2002, Mr. Dykan was the Chairman and Chief Executive Officer of BitBand Inc. Mr. Dykan is a member of the American Institute of CPAs and holds a B.Sc. in accounting and management and an MBA in computer applications, both from New York University.

What is Jeff Dykan's net worth?: The estimated net worth of Jeff Dykan is at least $0.00 as of August 16th, 2023. Mr. Dykan owns 57,162 shares of ReWalk Robotics stock worth more than $0 as of April 20th. This net worth approximation does not reflect any other investments that Mr. Dykan may own. Learn More about Jeff Dykan's net worth.
How do I contact Jeff Dykan?: The corporate mailing address for Mr. Dykan and other ReWalk Robotics executives is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. ReWalk Robotics can also be reached via phone at (724) 959-0123 and via email at [email protected]. Learn More on Jeff Dykan's contact information.
Has Jeff Dykan been buying or selling shares of ReWalk Robotics?: Jeff Dykan has not been actively trading shares of ReWalk Robotics during the past quarter. Most recently, on Wednesday, August 16th, Jeff Dykan bought 15,000 shares of ReWalk Robotics stock. The stock was acquired at an average cost of $0.60 per share, with a total value of $9,000.00. Following the completion of the transaction, the director now directly owns 57,162 shares of the company's stock, valued at $34,297.20. Learn More on Jeff Dykan's trading history.
Who are ReWalk Robotics' active insiders?: ReWalk Robotics' insider roster includes Jeff Dykan (Director), and Lawrence Jasinski (CEO). Learn More on ReWalk Robotics' active insiders.
Are insiders buying or selling shares of ReWalk Robotics?: In the last year, ReWalk Robotics insiders bought shares 13 times. They purchased a total of 5,293,908 shares worth more than $3,707,063.72. In the last year, insiders at the medical device company sold shares 5 times. They sold a total of 69,619 shares worth more than $44,828.55. The most recent insider tranaction occured on September, 26th when Major Shareholder Global Fund Lp Lind II bought 5,031,200 shares worth more than $3,521,840.00. Insiders at ReWalk Robotics own 2.1% of the company. Learn More about insider trades at ReWalk Robotics.
Information on this page was last updated on 9/26/2023.

Jeff Dykan Insider Trading History at ReWalk Robotics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/16/2023	Buy	15,000	$0.60	$9,000.00	57,162
6/7/2022	Buy	15,000	$1.00	$15,000.00	25,618
11/15/2021	Sell	4,129	$1.53	$6,317.37
6/26/2017	Sell	37,030	$3.00	$111,090.00
6/1/2016	Sell	11,370	$7.74	$88,003.80
5/26/2016	Sell	27,022	$8.69	$234,821.18
5/23/2016	Sell	1,200	$9.00	$10,800.00
1/15/2016	Sell	50,000	$10.30	$515,000.00

Jeff Dykan Buying and Selling Activity at ReWalk Robotics

ReWalk Robotics Company Overview

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Today's Range

Now: N/A

50 Day Range

MA: $0.94

$0.64

$1.25

2 Week Range

Now: N/A

Volume

303,600 shs

Average Volume

541,468 shs

Market Capitalization

$63.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.3